Literature DB >> 3486890

An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor.

D C Lynch, T S Zimmerman, E H Ling, P J Browning.   

Abstract

Initial synthesis of von Willebrand factor (vWf) by cultured human endothelial cells proceeds by formation of a dimer of pro-vWf subunits. These subunits are found only within the cell and have an apparent molecular weight of 240,000-260,000, as measured by electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. Posttranslational modifications, including proteolytic cleavage, glycosylation, and sulfation, result in the appearance of two additional vWf subunits. The major one migrates with the subunit of plasma vWf at an apparent molecular weight of 220,000-225,000 and the other migrates more slowly than pro-vWf at an apparent molecular weight of 260,000-275,000. These subunits oligomerize to form a set of vWf multimers, which are subsequently secreted into the culture medium. We isolated individual vWf oligomer species from the agarose gel bands and show that vWf minor, or satellite, species differ from major species in subunit composition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486890      PMCID: PMC370567          DOI: 10.1172/JCI112535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Isolation and characterization of human Factor VIII (antihemophilic factor).

Authors:  M E Legaz; G Schmer; R B Counts; E W Davie
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

Review 2.  The factor VIII complex: structure and function.

Authors:  L W Hoyer
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

3.  Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells.

Authors:  D C Lynch; R Williams; T S Zimmerman; E P Kirby; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

4.  A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers.

Authors:  P M Mannucci; R Lombardi; F I Pareti; S Solinas; M G Mazzucconi; G Mariani
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

5.  Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain.

Authors:  D D Wagner; V J Marder
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

6.  Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

7.  Studies on the relationship between factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg) by immunoelectrophoresis and autoradiography using 125I anti VIIICAg.

Authors:  B L Davies; R A Furlong; I R Peake
Journal:  Thromb Res       Date:  1981 Apr 1-15       Impact factor: 3.944

8.  Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC).

Authors:  Z M Ruggeri; I M Nilsson; R Lombardi; L Holmberg; T S Zimmerman
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

9.  Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers.

Authors:  L W Hoyer; J R Shainoff
Journal:  Blood       Date:  1980-06       Impact factor: 22.113

10.  Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

Authors:  T S Zimmerman; J A Dent; Z M Ruggeri; L H Nannini
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

View more
  5 in total

1.  Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.

Authors:  R B Levene; F M Booyse; J Chediak; T S Zimmerman; D M Livingston; D C Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.

Authors:  J A Dent; M Galbusera; Z M Ruggeri
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.

Authors:  J Voorberg; R Fontijn; J A van Mourik; H Pannekoek
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

4.  Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation.

Authors:  C L Verweij; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

5.  Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells.

Authors:  B M Ewenstein; M J Warhol; R I Handin; J S Pober
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.